InvestorsHub Logo
Followers 0
Posts 21
Boards Moderated 0
Alias Born 04/19/2017

Re: attilathehunt post# 5860

Tuesday, 05/09/2017 2:36:35 PM

Tuesday, May 09, 2017 2:36:35 PM

Post# of 6306
The Objective Performance Criteria is definitely defined by FDA at 25%. INSPIRE results are significantly better. Once this is approved I think the pressure will be strong to make it the new SOC. If InVivo charges $100K and has 2000 to 3200 patients per year, this will fly pretty high. The margin will be high, with a small sales force and manufacturing scale-up will be the biggest project to work out. I am actually quite optimistic on how this turns out.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.